Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types

Emami Ltd0 个研究点目标入组 24 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•Phase I; Voluntary men and women ratio of 1:1 between 18 and 65 years.
•â?? Phase II; Voluntary boy and girl ratio of 1:1 between 12 and 17 years.
•â?? Having healthy skin on test area as assessed by dermatological examination.
•â?? For whom the investigator considers that the compliance will be correct.
•â?? Subjects with normal, dry, oily and combination skin

•Pregnant/nursing mothers.
•â?? Scars, excessive terminal hair, or tattoo on the studied area.
•â?? Dermatological infection/pathology on level of studied area.
•â?? Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
•â?? Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or
•procedures.

发起方

Emami Ltd